Pressure Biosciences (PBIO) Stock Price, Forecast & Analysis

NASDAQ:PBIO

3.39
+2.78 (+455.74%)
Last: Sep 5, 2017, 07:07 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

PBIO Key Statistics, Chart & Performance

Key Statistics
Market Cap3.73M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares1.10M
Float880.00K
52 Week High3.45
52 Week Low0.1
Yearly Dividend0
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
PBIO short term performance overview.The bars show the price performance of PBIO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 100 200 300 400

PBIO long term performance overview.The bars show the price performance of PBIO in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of PBIO is 3.39 null. In the past month the price increased by 465%. In the past year, price increased by 202.68%.

Pressure Biosciences / PBIO Daily stock chart

PBIO Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to PBIO. When comparing the yearly performance of all stocks, PBIO is one of the better performing stocks in the market, outperforming 99.66% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
PBIO Full Technical Analysis Report

PBIO Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to PBIO. PBIO has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PBIO Full Fundamental Analysis Report

PBIO Financial Highlights


Industry RankSector Rank
PM (TTM) 100.05%
ROA -653.69%
ROE 0%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
PBIO financials

PBIO Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
PBIO Analyst EstimatesPBIO Analyst Ratings

PBIO Ownership

Ownership
Inst Owners0.55%
Ins Owners36.88%
Short Float %N/A
Short RatioN/A
PBIO Ownership

About PBIO

Company Profile

Pressure BioSciences, Inc is a company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (35,000 psi and greater) to control bio- molecular interactions. Pressure BioSciences holds US and foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification.

Company Info

Pressure Biosciences

14 NORFOLK AVENUE

SOUTH EASTON MA 02375

CEO: Richard T. Schumacher

Phone: 508-230-1828

Pressure Biosciences / PBIO FAQ

Can you describe the business of Pressure Biosciences?

Pressure BioSciences, Inc is a company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (35,000 psi and greater) to control bio- molecular interactions. Pressure BioSciences holds US and foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification.


What is the current price of PBIO stock?

The current stock price of PBIO is 3.39 null. The price increased by 455.74% in the last trading session.


What is the dividend status of Pressure Biosciences?

PBIO does not pay a dividend.


How is the ChartMill rating for Pressure Biosciences?

PBIO has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.